Search Results - "Carvalho, Eva D."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Hydrogel-Assisted Antisense LNA Gapmer Delivery for In Situ Gene Silencing in Spinal Cord Injury by Moreno, Pedro M.D., Ferreira, Ana R., Salvador, Daniela, Rodrigues, Maria T., Torrado, Marília, Carvalho, Eva D., Tedebark, Ulf, Sousa, Mónica M., Amaral, Isabel F., Wengel, Jesper, Pêgo, Ana P.

    Published in Molecular therapy. Nucleic acids (01-06-2018)
    “…After spinal cord injury (SCI), nerve regeneration is severely hampered due to the establishment of a highly inhibitory microenvironment at the injury site,…”
    Get full text
    Journal Article
  2. 2

    The interplay between chemical conjugation and biologic performance in the development of alginate-based 3D matrices to mimic neural microenvironments by Carvalho, Eva D., Morais, Miguel R.G., Pêgo, Ana P., Barrias, Cristina C., Araújo, Marco

    Published in Carbohydrate polymers (01-01-2024)
    “…Biofunctionalization of polysaccharides is a widely used strategy for obtaining extracellular matrix (ECM)-mimicking biomaterials. Still, commonly employed…”
    Get full text
    Journal Article
  3. 3

    A paradigm shift: Bioengineering meets mechanobiology towards overcoming remyelination failure by Carvalho, Eva D., Morais, Miguel R.G., Ferreira, Helena P., Silva, Mariana M.C., Guimarães, Sofia C., Pêgo, Ana P.

    Published in Biomaterials (01-04-2022)
    “…Therapeutic strategies aimed at overcoming the loss of myelin sheath in central nervous system demyelinating diseases are often unsuccessful due to nescience…”
    Get full text
    Journal Article
  4. 4

    High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases by Rocha, Daniela N., Carvalho, Eva D., Pêgo, Ana Paula

    Published in Drug discovery today (01-09-2016)
    “…•Simple and robust readout methods are crucial to the success of an HTS platform.•Molecular gradients are important regulatory components of tissue…”
    Get full text
    Journal Article
  5. 5

    High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases: Foundation by Rocha, Daniela N, Carvalho, Eva D, Pego, Ana Paula

    Published in Drug discovery today (01-09-2016)
    “…Despite the recent progress in the understanding of neurodegenerative disorders, a lack of solid fundamental knowledge on the etiology of many of the major…”
    Get full text
    Journal Article